X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21153) 21153
Book Review (3871) 3871
Publication (1524) 1524
Book Chapter (232) 232
Conference Proceeding (179) 179
Dissertation (116) 116
Magazine Article (41) 41
Newsletter (31) 31
Book / eBook (12) 12
Paper (6) 6
Web Resource (5) 5
Data Set (2) 2
Journal / eJournal (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15852) 15852
humans (10785) 10785
animals (7627) 7627
glycation end-products (7036) 7036
male (5591) 5591
oxidative stress (4770) 4770
glycation (4088) 4088
female (3866) 3866
diabetes (3840) 3840
glycation end products, advanced - metabolism (3539) 3539
biochemistry & molecular biology (3134) 3134
rats (2898) 2898
middle aged (2801) 2801
proteins (2798) 2798
glycosylation (2658) 2658
receptor for advanced glycation end products (2655) 2655
advanced glycation end products (2546) 2546
mice (2403) 2403
endocrinology & metabolism (2312) 2312
inflammation (2258) 2258
aged (2161) 2161
glucose (2064) 2064
adult (1993) 1993
maillard reaction (1944) 1944
rage (1862) 1862
receptor (1800) 1800
diabetes mellitus (1797) 1797
expression (1689) 1689
complications (1584) 1584
cell biology (1575) 1575
pharmacology & pharmacy (1545) 1545
atherosclerosis (1418) 1418
age (1367) 1367
risk factors (1362) 1362
analysis (1355) 1355
cells, cultured (1325) 1325
receptors, immunologic - metabolism (1325) 1325
research (1267) 1267
in-vitro (1209) 1209
disease (1201) 1201
end-products (1184) 1184
methylglyoxal (1131) 1131
urology & nephrology (1130) 1130
food science & technology (1122) 1122
physiological aspects (1113) 1113
medicine, research & experimental (1110) 1110
activation (1100) 1100
apoptosis (1098) 1098
advanced glycation endproducts (1068) 1068
hyperglycemia (1056) 1056
collagen (1055) 1055
lysine - analogs & derivatives (1030) 1030
protein (1019) 1019
health aspects (1017) 1017
aging (1009) 1009
cells (999) 999
glycation end products, advanced - blood (982) 982
article (958) 958
signal transduction (900) 900
mellitus (871) 871
diabetes-mellitus (866) 866
neurosciences (850) 850
advanced glycosylation end products (844) 844
rats, wistar (834) 834
abridged index medicus (830) 830
rats, sprague-dawley (829) 829
antioxidants (800) 800
type 2 diabetes (798) 798
nonenzymatic glycation (790) 790
disease models, animal (787) 787
endothelial-cells (765) 765
biophysics (762) 762
reactive oxygen species - metabolism (761) 761
diabetic complications (751) 751
rodents (743) 743
oxidation-reduction (742) 742
immunohistochemistry (738) 738
ages (728) 728
pathogenesis (722) 722
immunology (712) 712
dextrose (711) 711
peripheral vascular disease (709) 709
biomarkers - blood (708) 708
cattle (705) 705
mice, inbred c57bl (700) 700
aged, 80 and over (698) 698
care and treatment (697) 697
advanced glycation end-products (694) 694
glucose - metabolism (692) 692
time factors (692) 692
receptors, immunologic - genetics (691) 691
alzheimers-disease (690) 690
enzyme-linked immunosorbent assay (689) 689
in-vivo (681) 681
oxidative stress - drug effects (681) 681
endproducts (678) 678
insulin-resistance (676) 676
multidisciplinary sciences (675) 675
physiology (670) 670
fluorescence (666) 666
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20464) 20464
Japanese (240) 240
Chinese (214) 214
German (123) 123
French (118) 118
Spanish (74) 74
Korean (66) 66
Italian (60) 60
Russian (52) 52
Polish (48) 48
Czech (34) 34
Portuguese (23) 23
Hungarian (18) 18
Turkish (8) 8
Slovak (7) 7
Romanian (6) 6
Bulgarian (3) 3
Serbian (3) 3
Swedish (3) 3
Ukrainian (3) 3
Norwegian (2) 2
Persian (2) 2
Belarusian (1) 1
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Nutrition, ISSN 0007-1145, 12/2015, Volume 115, Issue 4, pp. 629 - 636
Dietary advanced glycation end products (AGE) formed during heating of food have gained interest as potential nutritional toxins with adverse effects on... 
Advanced glycation end products | Gene for advanced glycation end product receptor 1 | Insulin sensitivity | Gene for receptor for advanced glycation end products | Rats | Gene expression | Body composition | METABOLIC TRANSIT | LIFE-SPAN | ACTIVATION | OXIDANT STRESS | FOODS | GLYCOTOXINS | ENDPRODUCTS AGES | NUTRITION & DIETETICS | RESTRICTED INTAKE | INSULIN-RESISTANCE | MICE | Tumor Necrosis Factor-alpha - metabolism | Up-Regulation | Glycation End Products, Advanced - administration & dosage | Biomarkers - urine | Molecular Weight | Lysine - urine | Diet - adverse effects | Tumor Necrosis Factor-alpha - blood | Tumor Necrosis Factor-alpha - genetics | Milk Proteins - adverse effects | Male | Hexosyltransferases - metabolism | Milk Proteins - administration & dosage | Milk Proteins - chemistry | Proteolysis | Glycation End Products, Advanced - adverse effects | Receptor for Advanced Glycation End Products - genetics | Hexosyltransferases - blood | Receptor for Advanced Glycation End Products - blood | Lysine - analogs & derivatives | Hot Temperature - adverse effects | Receptor for Advanced Glycation End Products - metabolism | Hexosyltransferases - genetics | Biomarkers - blood | Random Allocation | Receptor for Advanced Glycation End Products - agonists | Energy Intake | Rats, Sprague-Dawley | Glycation End Products, Advanced - urine | Renal Elimination | Animals | Glycation End Products, Advanced - chemistry | Toxicity Tests, Subacute | Hexosyltransferases - chemistry | Imidazolines - urine | Imidazoles - urine | Index Medicus
Journal Article
Diabetes, ISSN 0012-1797, 12/2015, Volume 64, Issue 12, pp. 4046 - 4060
Diabetes exacerbates cardiovascular disease, at least in part through suppression of macrophage cholesterol efflux and levels of the cholesterol transporters... 
SIGNALING PATHWAYS | ATHEROSCLEROTIC PLAQUES | GENERAL CONTRASTS | STATIN THERAPY | FOAM-CELL-FORMATION | IN-VIVO | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | PPAR-GAMMA | DEFICIENT MICE | GLYCATION END-PRODUCTS | ATP Binding Cassette Transporter, Sub-Family G, Member 1 | Lipoproteins - genetics | Humans | Male | Aorta - metabolism | PPAR gamma - metabolism | ATP Binding Cassette Transporter 1 - metabolism | Lipoproteins - antagonists & inhibitors | Diabetic Angiopathies - pathology | ATP-Binding Cassette Transporters - genetics | Biological Transport | Lipoproteins - metabolism | ATP-Binding Cassette Transporters - metabolism | Plaque, Atherosclerotic - blood | Receptor for Advanced Glycation End Products - genetics | Plaque, Atherosclerotic - pathology | Macrophages - immunology | PPAR gamma - genetics | Receptor for Advanced Glycation End Products - blood | Recombinant Proteins - metabolism | Cell Line | Diabetic Angiopathies - metabolism | Promoter Regions, Genetic | Macrophages - pathology | Plaque, Atherosclerotic - metabolism | Receptor for Advanced Glycation End Products - metabolism | Cells, Cultured | Recombinant Proteins - chemistry | Aorta - immunology | Diabetic Angiopathies - blood | Macrophages - cytology | Plaque, Atherosclerotic - immunology | Receptor for Advanced Glycation End Products - agonists | Cholesterol - metabolism | Mice, Knockout | Aorta - pathology | Macrophages - metabolism | Animals | Diabetic Angiopathies - immunology | Glycation End Products, Advanced - metabolism | Glycation End Products, Advanced - blood | Ligands | ATP Binding Cassette Transporter 1 - genetics | ATP-Binding Cassette Transporters - antagonists & inhibitors | Diabetic acidosis | Care and treatment | Ketoacidosis | Research | Cardiovascular diseases | Macrophages | Risk factors | Cardiovascular disease | Diabetes | Rodents | Cholesterol | Adenosine triphosphatase | Index Medicus | Abridged Index Medicus | Metabolism
Journal Article
Journal Article
Diabetes, ISSN 0012-1797, 06/2017, Volume 66, Issue 6, pp. 1683 - 1695
The interaction of advanced glycation end products (AGEs) and their receptor (RAGE) plays a central role in diabetic nephropathy. We screened DNA aptamers... 
VASCULAR COMPLICATIONS | OXIDATIVE STRESS | METABOLIC MEMORY | ENDOTHELIAL-CELLS | IN-VIVO | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | RECEPTOR | RENAL-DISEASE | BIOCHEMICAL BASIS | GLYCATION END-PRODUCTS | Rats, Wistar | Humans | NADPH Oxidases - metabolism | Male | Receptor for Advanced Glycation End Products - antagonists & inhibitors | Albuminuria | Mesangial Cells - drug effects | Kidney - metabolism | NADPH Oxidases - drug effects | Receptor for Advanced Glycation End Products - genetics | Diabetes Mellitus, Experimental - metabolism | Real-Time Polymerase Chain Reaction | Aptamers, Nucleotide - pharmacology | Fibrosis - genetics | Kidney - drug effects | Enzyme-Linked Immunosorbent Assay | Diabetic Nephropathies - metabolism | Receptor for Advanced Glycation End Products - metabolism | Rats | Chemokine CCL2 - genetics | Glycation End Products, Advanced - drug effects | Gene Expression Regulation - drug effects | Animals | Podocytes - drug effects | Glycation End Products, Advanced - metabolism | Mesangial Cells - pathology | Inflammation - genetics | Receptor for Advanced Glycation End Products - drug effects | Oxidative Stress - drug effects | Chemokine CCL2 - drug effects | Oxidative stress | Development and progression | Research | Streptozocin | Diabetic nephropathies | Advanced glycosylation end products | Kidneys | Peptides | Diabetes mellitus | Glycosylation | Inflammation | Macrophages | Experiments | NAD(P)H oxidase | Molecules | Nephropathy | Rodents | Aptamers | Mesangial cells | Extracellular matrix | Diabetes | Kidney diseases | Monocyte chemoattractant protein 1 | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 03/2010, Volume 298, Issue 3, pp. F763 - F770
Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, Thomas MC, O'Brien RC, Bierhaus A, Cooper ME, Forbes JM, Coughlan MT. Disparate... 
Advanced glycation | Advanced glycation end products | Receptor of advanced glycation end products | advanced glycation | PHYSIOLOGY | ALBUMINURIA | PREVENTION | RATS | TERM | GLYCOXIDATION PRODUCTS | advanced glycation end products | GENE-EXPRESSION | UROLOGY & NEPHROLOGY | MICE | DYSFUNCTION | receptor of advanced glycation end products | STRESS | GLYCATION END-PRODUCTS | Diabetes Mellitus, Experimental - drug therapy | Glycation End Products, Advanced - administration & dosage | Diabetic Nephropathies - etiology | Diabetic Nephropathies - drug therapy | Male | Membrane Potential, Mitochondrial - drug effects | Glycolysis - drug effects | Creatinine - metabolism | Kidney - metabolism | Time Factors | Mitochondrial Proteins - metabolism | Adenosine Triphosphate - metabolism | Superoxides - metabolism | Albuminuria - metabolism | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Experimental - metabolism | Receptor for Advanced Glycation End Products | Disease Models, Animal | Kidney - drug effects | Albuminuria - etiology | Diabetic Nephropathies - metabolism | Mice, Inbred C57BL | Receptors, Immunologic - deficiency | Mitochondria - metabolism | Mitochondria - drug effects | Disease Progression | Mice, Knockout | Animals | Diet | Ion Channels - metabolism | Albuminuria - drug therapy | Glycation End Products, Advanced - metabolism | Mice | Thiazoles - pharmacology | Uncoupling Protein 2 | Oxidative Stress - drug effects | Receptors, Immunologic - genetics | Diet therapy | Diabetic nephropathies | Development and progression | Genetic aspects | Glycosylation | Research | Gene expression | Observations | Properties | Membranes | Kidneys | Rodents | T cell receptors | Oxidation | Adenosine triphosphatase | Index Medicus
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2015, Volume 764, pp. 554 - 561
Stable microtubules (MTs) is involved the mechanism of diabetic cardiomyopathy (DCM), which is induced by acetylation of α-tubulin. The present study... 
Acetylated α-tubulin | Diabetic cardiomyopathy | Advanced glycation end products | Aminoguanidine | Receptor for advanced glycation end products | SIRT2 | APOPTOSIS | CELLS | CONTRIBUTE | ACETYLATION | SIRTUINS | Acetylated alpha-tubulin | ALPHA-TUBULIN | PHARMACOLOGY & PHARMACY | GLYCATION END-PRODUCTS | Ventricular Function, Left | Diabetes Mellitus, Experimental - enzymology | Diabetes Mellitus, Experimental - genetics | Male | Diabetic Cardiomyopathies - physiopathology | Sirtuin 2 - metabolism | Myocytes, Cardiac - enzymology | Tubulin - metabolism | Transfection | RNA Interference | Echocardiography, Doppler | Acetylation | Protein Stability | Receptor for Advanced Glycation End Products - genetics | Diabetes Mellitus, Experimental - physiopathology | Diabetic Cardiomyopathies - enzymology | Diabetes Mellitus, Type 1 - enzymology | Signal Transduction | Diabetes Mellitus, Type 1 - physiopathology | Receptor for Advanced Glycation End Products - metabolism | Cells, Cultured | Diabetes Mellitus, Type 1 - genetics | Rats, Sprague-Dawley | Diabetic Cardiomyopathies - genetics | Gene Expression Regulation, Enzymologic | Sirtuin 2 - genetics | Animals | Glycation End Products, Advanced - metabolism | Microtubules - enzymology | Protein Binding | Ventricular Pressure | Immunohistochemistry | Heart | Cardiomyopathy | Type 1 diabetes | Analysis | Genetic engineering | Tubulins | Heart diseases | Index Medicus
Journal Article
Matrix Biology, ISSN 0945-053X, 05/2017, Volume 59, pp. 39 - 53
Advanced glycation endproducts (AGEs) are a heterogeneous group of compounds that form via non-enzymatic glycation of proteins throughout our lifespan and at a... 
Non-enzymatic glycation | Extracellular matrix | Advanced glycation endproducts | RAGE | Mass spectrometry | Fibronectin | ATHEROSCLEROTIC LESIONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MASS-SPECTROMETRY | CELL BIOLOGY | HUMAN LENS PROTEINS | DIABETES-MELLITUS | GLOMERULAR MESANGIAL CELLS | GROWTH-FACTOR-BETA | NONENZYMATIC GLYCATION | MDIA-INTERACTING PROTEIN | EXTRACELLULAR-MATRIX | END-PRODUCTS | NIH 3T3 Cells | Humans | Extracellular Matrix - metabolism | Integrins - genetics | Receptor for Advanced Glycation End Products - antagonists & inhibitors | Integrins - metabolism | Extracellular Matrix - chemistry | Mesangial Cells - drug effects | Cattle | Fibronectins - agonists | Receptor for Advanced Glycation End Products - genetics | Amino Acid Sequence | Serum Albumin, Bovine - pharmacology | Gene Expression | Pyruvaldehyde - pharmacology | Signal Transduction | Extracellular Matrix - drug effects | Oligopeptides - genetics | Receptor for Advanced Glycation End Products - metabolism | Rats | Antibodies, Neutralizing - pharmacology | Mesangial Cells - metabolism | Oligopeptides - metabolism | Fibronectins - metabolism | Animals | Fibronectins - chemistry | Glycation End Products, Advanced - pharmacology | Models, Biological | Fibrosis | Mesangial Cells - pathology | Fibronectins - genetics | Mice | Pyruvaldehyde - chemistry | Cell Line, Transformed | Fibronectins | Enzymes | Analysis | Chronic diseases | Development and progression | Gene expression | Integrins | Albumin | Bovine serum albumin | Immunoglobulins | Advanced glycosylation end products | Diabetes mellitus | Blocking antibodies | Cystic fibrosis | Mass spectroscopy | Glycosylation | Cell interactions | Proteins | Stimulants | Life span | Mesangial cells | Pyruvaldehyde | Chronic illnesses | Index Medicus | mass spectrometry | non-enzymatic glycation | advanced glycation endproducts | extracellular matrix
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2014, Volume 111, Issue 13, pp. 4940 - 4945
Age-associated dementia and Alzheimer's disease (AD) are currently epidemic. Neither their cause nor connection to the metabolic syndrome (MS) is clear.... 
Anger | Brain | Advanced glycosylation end products | Diet | Neurons | Mice | Cognition | Type 2 diabetes mellitus | Diabetes | Alzheimers disease | Obesity | Insulin resistance | Nutrition | Caloric restriction | Neural | caloric restriction | neural | MULTIDISCIPLINARY SCIENCES | COGNITIVE FUNCTION | DIABETES-MELLITUS | nutrition | INSULIN-RESISTANCE | AMYLOID-BETA | ALZHEIMERS-DISEASE PATIENTS | insulin resistance | POTENTIAL ROLE | obesity | BRAIN | METHYLGLYOXAL | GLYCATION END-PRODUCTS | CALORIE RESTRICTION | Amyloid Precursor Protein Secretases - genetics | Transcription, Genetic - drug effects | Glycation End Products, Advanced - administration & dosage | Pyruvaldehyde - administration & dosage | Humans | Middle Aged | Dementia - physiopathology | Male | Glycation End Products, Advanced - toxicity | PPAR gamma - metabolism | Metabolic Syndrome - blood | Time Factors | Amyloid beta-Peptides - metabolism | Pyruvaldehyde - toxicity | Receptor for Advanced Glycation End Products | Dementia - pathology | Administration, Oral | Membrane Proteins - genetics | Brain - physiopathology | Cognition - drug effects | Brain - drug effects | ADAM Proteins - metabolism | Amyloid Precursor Protein Secretases - metabolism | Brain - pathology | Dementia - blood | Metabolic Syndrome - pathology | Oxidative Stress - drug effects | ADAM Proteins - genetics | Pyruvaldehyde - blood | Memory - drug effects | Sirtuin 1 - metabolism | Pyruvaldehyde - adverse effects | Gliosis - physiopathology | Gliosis - pathology | Nicotinamide Phosphoribosyltransferase - metabolism | Metabolic Syndrome - physiopathology | Female | Glycation End Products, Advanced - adverse effects | Membrane Proteins - metabolism | Insulin - pharmacology | Cytokines - metabolism | Gliosis - metabolism | Mice, Inbred C57BL | ADAM10 Protein | Sirtuin 1 - antagonists & inhibitors | Animals | Aged | Receptors, Immunologic - metabolism | Causes of | Metabolic diseases | Toxins | Health aspects | Dementia | Oxidative stress | Metabolic syndrome | Gene expression | Index Medicus | Biological Sciences
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2005, Volume 20, Issue 9, pp. 1647 - 1658
The impact of AGEs on human MSCs was studied. AGEs inhibited the proliferation of MSCs, induced apoptosis, and prevented cognate differentiation into adipose... 
receptor for advanced glycation end‐products | differentiation | advanced glycation end‐products | proliferation | mesenchymal stem cells | Advanced glycation end-products | Proliferation | Differentiation | Receptor for advanced glycation end-products | Mesenchymal stem cells | DIABETIC COMPLICATIONS | ALDEHYDE DEHYDROGENASE | MAILLARD REACTION | RECEPTOR | advanced glycation end-products | OSTEOBLAST-LIKE CELLS | ENDOCYTIC UPTAKE | ENDOTHELIAL-CELLS | IN-VIVO | ENDOCRINOLOGY & METABOLISM | EXTRACELLULAR-MATRIX | GROWTH-FACTOR EXPRESSION | receptor for advanced glycation end-products | Immunohistochemistry | Bone and Bones - pathology | Chondrocytes - cytology | Cell Proliferation | Reactive Oxygen Species | Calcium - metabolism | Cartilage - pathology | Microscopy, Phase-Contrast | Humans | Adipose Tissue - cytology | Adipocytes - cytology | Stem Cells - cytology | Wound Healing | Microscopy, Immunoelectron | Dose-Response Relationship, Drug | Mesenchymal Stromal Cells - cytology | Time Factors | Cartilage - cytology | Acetaldehyde - pharmacology | Bone and Bones - cytology | Collagen Type II - biosynthesis | Cell Line | Glycation End Products, Advanced - physiology | Phenazines - pharmacology | Enzyme-Linked Immunosorbent Assay | Osteocytes - metabolism | Cell Survival | Adipose Tissue - pathology | Cells, Cultured | Glucose - pharmacology | Lipoprotein Lipase - biosynthesis | Blotting, Western | Bromodeoxyuridine - pharmacology | Cell Differentiation - drug effects | Glycation End Products, Advanced - metabolism | Glyceraldehyde - pharmacology | Microscopy, Fluorescence | Acetaldehyde - analogs & derivatives | Apoptosis | Index Medicus
Journal Article